EACS Guidelines
Advanced Search…
  • Log in
  • Home
  • Contents
    • Summary of Changes from v.11.1 to v.12.0
    • Abbreviations
    • Version Information
  • Assessment
  • ART
    • Readiness to Start/Maintain ART
    • Initiation of ART: No Prior ART Exposure
    • Initial Regimens: ART-naïve Adults
    • Primary HIV Infection (PHI)
    • Switch Strategies
    • Virological Failure
    • Pregnancy and HIV
    • ART: TB/HIV Co-infection
    • Post-exposure Prophylaxis (PEP)
    • Pre-exposure Prophylaxis (PrEP)
    • ARV Adverse Effects & Drug Classes
  • DDIs & Prescribing Issues
    • DDIs, Prescribing, Overview
    • Drug-drug interactions
      • ARVs & non-ARVs
      • Analgesics & ARVs
      • Anticoagulants/Antiplatelet Agents & ARVs
      • Antidepressants & ARVs
      • Antihypertensives & ARVs
      • Anti-infective Drugs for OIs and STIs and ARVs
      • Anti-malarial Drugs & ARVs
      • Anti-tuberculosis Drugs & ARVs
      • Anxiolytics & ARVs
      • Bronchodilators & ARVs
      • Contraceptives & ARVs
      • Corticosteroids & ARVs
      • COVID-19 Therapies & ARVs
      • Hormone Replacement Therapy (HRT) & ARVs
      • Immunosuppressants & ARVs
      • Pulmonary Antihypertensives & ARVs
      • Viral Hepatitis Drugs & ARVs
    • Other prescribing issues
      • ARVs: Swallowing Difficulties
      • ARV Dosing: Hepatic Impairment
      • ARV Dosing: Renal Impairment
      • Non-ARV Drug Dosing: Renal Insufficiency
      • Prescribing in Older Persons with HIV
      • Drug Classes To Avoid in Older Persons with HIV
      • Drug Classes to Deprescribe in Older Persons with HIV in Presence of Certain Conditions
      • Hormone Therapy: Gender Transitioning
  • Co-morbidities
    • Co-morbidities, Overview
    • Substance Use: Alcohol
    • Opioid Addiction, Pharmacological Treatment
    • Cancer
      • Cancer: Screening Methods
      • Cancer: Treatment Monitoring
    • Lifestyle Interventions
    • Cardiovascular Disease
      • Prevention of Cardiovascular Disease (CVD)
      • Hypertension: Diagnosis, Grading & Management
      • Hypertension: Drug Sequencing Management*
      • DDIs: Anti-hypertensives & ARVs
    • Type 2 Diabetes
    • Dyslipidemia
      • Dyslipidaemia
      • Treatment Goals for LDL-c to Reduce Cardiovascular Risk Depending on CV Risk Estimation*
    • Bone Disease
      • Bone Disease
      • Vitamin D Deficiency
      • Fracture Reduction
    • Kidney disease
      • Kidney Disease: Definition, Diagnosis and Management
      • ARV-associated Nephrotoxicity
      • Proximal Renal Tubulopathy (PRT)
      • ARV dosing: renal impairment
    • Liver Disease
      • Increased ALT/AST: Work-up & Management
      • Liver Cirrhosis: Classification, Surveillance
      • Liver Cirrhosis: Management
      • Non-Alcoholic Fatty Liver Disease (NAFLD)
      • Hepatorenal Syndrome /Acute Kidney Injury (HRS-AKI)
      • ARV Dosing: Hepatic Impairment
    • Lipodystrophy and Obesity:
    • Hyperlactataemia and Lactic Acidosis
    • Travel
      • Travel
      • Antimalarials & ARVs: DDI
    • Vaccination
    • Sexual, Reproductive Health
      • Sexual and Reproductive Health
      • Sexual Dysfunction
      • Treatment of Sexual Dysfunction
    • Mental Health: Depression & Anxiety Disorders
      • Depression: Screening, Diagnosis and Management
      • Antidepressants
      • DDI: Antidepressants and ARVs
      • Anxiety Disorders: Screening and Diagnosis
      • Anxiety Disorders: Management
      • Classification, Doses and Adverse Effects of Anxiolytics and Other Medications used to Treat Anxiety
      • DDI: Anxiolytics & ARVs
    • Cognitive Impairment
    • Use of Patient Reported Outcome Measures (PROMs) in HIV Clinical Care
    • Chronic Lung Disease
      • Chronic Lung Disease
      • DDI: Bronchodilators & ARVs
      • DDI: Pulmonary Antihypertensives & ARVs
    • Managing Older Persons with HIV
    • Frailty
    • Falls
    • Solid Organ Transplant (SOT)
      • Solid Organ Transplantation (SOT)
      • DDI: Immunosuppressants & ARVs
  • HIV/Hep Co-infection
    • Clinical Management and Treatment of Viral Hepatitis Co-infections
    • Treatment and Monitoring of Persons with HBV/HIV Co-infection
    • HCV/HIV Co-infection
      • Treatment and Monitoring of Persons with HCV/HIV Co-infection
      • HCV Treatment Options
      • DDIs: Viral Hepatitis Drugs & ARVs
    • Tests: Fibrosis / Cirrhosis
    • Hepatitis D and E infection
  • Opportunistic Infections, COVID-19
    • Overview, When to Start ART
    • Immune Reconstitution Inflammatory Syndrome (IRIS)
    • Primary Prophylaxis of OIs
    • Pneumocystis jirovecii Pneumonia (PcP)
    • Toxoplasma gondii Encephalitis
    • Cryptococcosis
    • Candidiasis
    • Histoplasmosis
    • Talaromycosis
    • Herpes simplex virus (HSV)
    • Varicella zoster virus (VZV)
    • Cytomegalovirus (CMV)
    • Progressive Multifocal Leukoencephalopathy (PML)
    • Bacillary Angiomatosis
    • Cryptosporidiosis
    • Non-Tuberculous Mycobacteria (NTM)
    • Cystoisosporiasis
    • Visceral Leishmaniasis
    • Tuberculosis
    • Management of COVID-19 in persons with HIV
    • Management of Mpox in Persons with HIV
  • Paediatric HIV Treatment
    • ART: Initiation and Initial Regimen
    • ART: Preferred & Alternative First Line Options, Formulations, Dosing
    • Switch Strategies, Special Situations
    • Adherence, Virological Failure and Second Line ART
    • General Principles of Postnatal Prophylaxis and Infant Feeding
  • References
    • References, Overview
    • Assessment of Initial & Subsequent Visits, References
    • ARV Treatment, References
    • DDIs & Other Prescribing Issues, References
    • Co-morbidities Prevention & Management, References
    • Chronic Viral Hepatitis Co-infections, References
    • Opportunistic Infections and COVID-19, References
    • Paediatric HIV Treatment References
  • EACS 2023 Images
    • Table Images 2023
      • Classification, Doses and Adverse Effects of Anxiolytics and Other Medications....png
      • Dose Adjustment of ARVs for Impaired Renal Function (1:2).png
      • Dose Adjustment of ARVs for Impaired Renal Function (2:2).png
      • Kidney Diagnosis - Large.png
You are here:
  1. Home
  2. EACS 2023 Images
  3. Table Images 2023
Table Images 2023 Table Images 2023 https://eacs.sanfordguide.com/eacs-2023-images/eacs-table-images-2023 https://eacs.sanfordguide.com/@@site-logo/eacs-logo.png

Table Images 2023

Table Images 2023
Classification, Doses and Adverse Effects of Anxiolytics and Other Medications....png Classification, Doses and Adverse Effects of Anxiolytics and Other Medications....png
Dose Adjustment of ARVs for Impaired Renal Function (1:2).png Dose Adjustment of ARVs for Impaired Renal Function (1:2).png
Dose Adjustment of ARVs for Impaired Renal Function (2:2).png Dose Adjustment of ARVs for Impaired Renal Function (2:2).png
Kidney Diagnosis - Large.png Kidney Diagnosis - Large.png
© EACS - All Rights Reserved | Privacy Policy